PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29949502-1	2018	PURPOSE: Ceftriaxone elimination occurs through breast cancer resistance transporter (BCRP) and multidrug resistance-associated protein 2 (MRP-2) which are expressed on the canalicular membrane of hepatocytes.	Ceftriaxone	9-20	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	48-84	
29949502-1	2018	PURPOSE: Ceftriaxone elimination occurs through breast cancer resistance transporter (BCRP) and multidrug resistance-associated protein 2 (MRP-2) which are expressed on the canalicular membrane of hepatocytes.	Ceftriaxone	9-20	ATP binding cassette subfamily G member 2 (Junior blood group)	Homo sapiens	86-90